Femoral Components

Femoral Components Market Outlook

The global femoral components market is projected to reach approximately USD 7.5 billion by 2035, growing at a robust CAGR of about 5.2% during the forecast period. This growth trajectory is primarily driven by the increasing prevalence of hip-related disorders and the aging population, leading to a higher demand for hip replacement surgeries. Additionally, advancements in surgical techniques and technologies, such as minimally invasive procedures, have significantly contributed to market expansion. Increasing healthcare expenditure, coupled with the rising awareness regarding the benefits of timely treatment for hip conditions, further fuels market growth. Moreover, the development of new product types and innovations in femoral component materials are expected to create lucrative opportunities for manufacturers in the coming years.

Growth Factor of the Market

One of the primary growth factors for the femoral components market is the increasing incidence of osteoarthritis and hip fractures, particularly among the geriatric population. As the global demographic trend leans toward an aging society, the demand for hip replacement surgeries, particularly total hip arthroplasties, is expected to rise significantly. Moreover, improvements in healthcare infrastructure and the availability of advanced orthopedic surgical techniques will encourage more patients to seek treatment. The emphasis on minimally invasive surgical methods and personalized surgical approaches is also projected to enhance recovery times and improve patient outcomes, making patients more likely to opt for surgeries. Additionally, as the technology behind femoral components evolves, the introduction of new and improved materials and designs can lead to longer-lasting and more effective solutions for patients, driving market growth.

Key Highlights of the Market

• The femoral components market is projected to grow at a CAGR of 5.2% from 2025 to 2035.
• North America holds the largest market share due to advanced healthcare systems and increased orthopedic procedures.
• Technological advancements in implant materials are enhancing the durability of femoral components.
• The rise of minimally invasive surgical techniques is expected to boost the adoption of femoral components significantly.
• Awareness programs and better healthcare policies are likely to improve patient access to surgical treatments.

By Product Type

Cemented Femoral Components:

Cemented femoral components have historically been a popular choice in hip arthroplasty due to their reliable fixation and ease of use during surgery. The cement acts as a bonding agent, securing the implant to the bone and allowing for immediate weight-bearing capabilities post-operation. These components are particularly beneficial for older patients with compromised bone quality, where optimal fixation is critical. The growing acceptance of cemented techniques, along with their successful track record in clinical outcomes, continues to drive their demand in the market. Furthermore, the development of advanced bone cements that offer improved mechanical properties and biocompatibility is expected to bolster the popularity of cemented femoral components in the coming years.

Cementless Femoral Components:

Cementless femoral components are gaining traction in the femoral components market as they utilize a porous surface that encourages bone ingrowth, leading to a more natural fixation over time. This type of implant is preferred in younger, more active patients due to its potential for long-term stability without the risks associated with cement degradation. The advancement in surface technology and materials for cementless designs has improved outcomes and reduced the need for revisions. Additionally, as the trend towards less invasive surgical approaches continues, cementless femoral components are increasingly seen as a viable option for hip arthroplasty, driving their market share upward.

Hybrid Femoral Components:

Hybrid femoral components combine features of both cemented and cementless designs, providing surgeons with flexibility in addressing individual patient needs. The hybrid approach allows for the use of cement on the femoral stem while leaving the acetabulum uncemented, promoting bone integration. This unique combination is particularly beneficial for patients with varying bone quality. As orthopedic surgeons seek to optimize patient outcomes, hybrid femoral components are gaining popularity due to their adaptability and the potential for reduced surgery time. The ongoing development and clinical success of hybrid designs are reflected in their increasing market presence.

Reverse Hybrid Femoral Components:

Reverse hybrid femoral components are a newer addition to the femoral market, designed to address specific clinical scenarios in hip arthroplasty. This design usually incorporates an uncemented stem with a cemented head, which provides stability while allowing for potential future revisions. The applications for reverse hybrid designs are particularly relevant in complex cases, such as patients with severe bone loss or deformities. As surgical techniques evolve and more surgeons gain experience with this innovative approach, reverse hybrid femoral components are projected to grow, capturing a segment of the market focused on complex hip surgeries.

Modular Femoral Components:

Modular femoral components offer an innovative approach to hip replacement by allowing customization during surgery. Surgeons can choose from various neck angles, lengths, and head sizes to create a tailored solution for each patient's anatomy. This adaptability enhances surgical outcomes and patient satisfaction, making modular designs increasingly popular among orthopedic surgeons. Furthermore, the ability to address a range of anatomical variations can potentially reduce complications associated with misalignment or improper fit. As the demand for personalized medicine grows, the modular femoral components segment is expected to see substantial growth, driven by advancements in implant technology.

By Application

Total Hip Arthroplasty:

Total hip arthroplasty (THA) is the most prominent application segment for femoral components, accounting for a significant share of the market. The procedure involves replacing the damaged hip joint with an artificial one, which necessitates reliable and durable femoral components for optimal patient outcomes. THA is particularly common among older adults suffering from severe arthritis or hip fractures. The increasing number of procedures performed globally, propelled by the aging population and growing obesity rates, ensures sustained demand for femoral components in this application. Furthermore, improved surgical techniques and patient education about the benefits of THA are likely to increase the number of surgeries conducted, thus impacting the femoral components market positively.

Hip Resurfacing:

Hip resurfacing is gaining attention as an alternative to traditional total hip arthroplasty, particularly in younger, active patients. This procedure involves capping the femoral head with a smooth metal surface, preserving more bone than a total replacement. As awareness about hip resurfacing grows, so does the demand for specialized femoral components designed for this application. The appealing outcomes and lower risk of dislocation associated with hip resurfacing procedures are significant factors driving their adoption. As a result, the femoral components market will continue to evolve to accommodate the unique needs of hip resurfacing patients, leading to increased availability and innovation in this segment.

Revision Hip Arthroplasty:

Revision hip arthroplasty is an essential application within the femoral components market, as it addresses the need for replacing or repairing previously implanted devices. The demand for revision surgeries is on the rise due to the increasing number of primary hip arthroplasties and the longevity of patients living with hip implants. These procedures often require specialized femoral components that can accommodate changes in anatomy and address complications such as implant loosening or infection. Consequently, the market for femoral components utilized in revision surgeries is expected to grow, driven by advancements in technology and materials tailored for complex cases.

Hip Fracture Management:

Hip fracture management is another crucial application segment that significantly impacts the femoral components market. The rising incidence of hip fractures, primarily due to falls among the elderly population, necessitates the use of reliable femoral components for stabilization and healing. Surgeons often rely on specialized implants that are designed to provide adequate support and restore mobility. As the global population ages, the demand for effective hip fracture management solutions is anticipated to increase, driving growth in this application segment. Additionally, the development of innovative devices and surgical techniques tailored for hip fracture repair will further enhance the market for femoral components.

Others:

The 'Others' segment encompasses various niche applications that utilize femoral components, including specific orthopedic procedures and emerging surgical techniques. As medical practice continues to evolve, the demand for specialized solutions tailored to unique patient needs and conditions is growing. This segment is expected to expand as awareness of alternative surgical options increases and new techniques are developed. Innovations in materials and designs catering to the 'Others' segment will play a crucial role in shaping the femoral components market's future, as healthcare providers seek to improve outcomes for diverse patient populations.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for femoral components, driven by the large volume of hip surgeries performed in these facilities. The availability of advanced surgical technologies and specialized orthopedic teams in hospitals enhances patient care and outcomes. Furthermore, hospitals typically have established partnerships with manufacturers, ensuring a steady supply of quality femoral components. The ongoing improvements in hospital infrastructure and surgical techniques will continue to support the growth of this distribution channel, making it a key player in the femoral components market.

Orthopedic Clinics:

Orthopedic clinics are becoming increasingly significant in the femoral components market, offering specialized services focused on joint replacement and orthopedic care. With the rise of outpatient procedures and advancements in minimally invasive techniques, more patients are seeking treatment in these settings. Orthopedic clinics provide tailored care that often results in shorter recovery times, attracting patients who wish to avoid longer hospital stays. The growth of orthopedic clinics as a distribution channel reflects the shift towards personalized, patient-centered healthcare, making it an essential part of the femoral components market landscape.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as an alternative distribution channel for femoral components, thanks to their efficiency and cost-effectiveness. These centers allow patients to undergo procedures and return home the same day, which is particularly appealing in today’s healthcare environment focused on reducing costs and improving convenience. ASCs are capable of providing high-quality care while minimizing patient wait times, thus encouraging more individuals to opt for elective surgeries like hip replacements. The increasing acceptance and growth of ASCs will likely enhance their role in the femoral components market as more procedures are performed in these facilities.

Online Platforms:

The rise of e-commerce has expanded the distribution channels for femoral components, with online platforms becoming an increasingly popular option for purchasing medical devices. These platforms provide easy access to a wide range of femoral components and allow healthcare professionals to research and compare products efficiently. The convenience of online ordering is driving interest among smaller clinics and practices that may not have direct access to manufacturers. While online platforms currently represent a smaller portion of the femoral components market, their growth potential is significant as the industry continues to embrace digital transformation and the demand for accessibility increases.

Others:

The 'Others' distribution channel includes various non-traditional sales avenues that contribute to the femoral components market. This may encompass direct sales from manufacturers, partnerships with distributors, or sales through specialized medical supply companies. As the market evolves, innovative distribution strategies will likely emerge, allowing for a more comprehensive delivery of femoral components to healthcare providers. The diversification of distribution channels will enhance market reach and ensure that various healthcare settings can access the necessary femoral components, ultimately benefiting patient care.

By Material Type

Metal-on-Polyethylene:

Metal-on-polyethylene is one of the most widely used combinations in femoral components, primarily due to its durability and low wear characteristics. This material pairing consists of a metal femoral head articulating against a polyethylene liner, providing a good balance of strength and performance. The long-standing track record of metal-on-polyethylene implants has established them as a standard in hip arthroplasty. With ongoing advancements in polyethylene technology to improve wear resistance, this material type is expected to maintain a strong position in the femoral components market, appealing especially to older patients seeking reliable and proven options for hip replacement.

Ceramic-on-Polyethylene:

Ceramic-on-polyethylene materials are gaining popularity in the femoral components market due to their excellent wear resistance and reduced risk of osteolysis. The use of a ceramic femoral head offers a smooth surface for articulation with a polyethylene liner, leading to lower friction and wear rates compared to metal-on-polyethylene combinations. This material type is particularly attractive to younger patients or those with higher activity levels seeking longevity from their implants. As advancements continue in ceramic technologies, increasing the strength and fracture toughness, the ceramic-on-polyethylene segment is expected to see considerable growth in the femoral components market.

Ceramic-on-Ceramic:

Ceramic-on-ceramic femoral components represent a cutting-edge option within the market, known for their exceptional wear properties and biocompatibility. This combination features a ceramic femoral head articulating against a ceramic liner, minimizing wear debris and the risk of osteolysis. Despite being a more expensive option, the potential for longer-lasting performance and lower revision rates makes ceramic-on-ceramic appealing for specific patient populations, particularly active individuals. As more surgeons gain familiarity and confidence in these advanced ceramic technologies, the demand for ceramic-on-ceramic femoral components is anticipated to rise, driving growth in this segment.

Metal-on-Metal:

Metal-on-metal femoral components have been a contentious topic within the orthopedic community due to concerns regarding wear debris and potential adverse health effects. However, when utilized appropriately, they can offer excellent durability and a reduced risk of dislocation. This material type consists of a metal femoral head articulating against a metal acetabular cup, allowing for a smaller implant size and greater range of motion. While regulatory scrutiny and patient safety concerns have impacted their market growth, ongoing improvements in metal formulations and surface finishes may revive interest in metal-on-metal femoral components among select patient groups.

Others:

The 'Others' material type category includes emerging materials and combinations that do not fit into traditional classifications. As research and development in orthopedic implants continue, novel materials may emerge that offer unique benefits such as enhanced osseointegration, improved mechanical properties, or reduced risks of adverse reactions. This segment represents an opportunity for innovation within the femoral components market, addressing unmet clinical needs and expanding the range of available options for patients and surgeons. Continued exploration of alternative materials will play a crucial role in shaping the future landscape of femoral components.

By Region

The femoral components market is currently dominated by North America, which accounted for over 40% of the global market share in 2023. This dominance can be attributed to the advanced healthcare infrastructure, high prevalence of hip disorders, and growing elderly population in the region. The U.S. is the leading contributor, supported by a well-established network of orthopedic surgeons, researchers, and manufacturers. The market in North America is anticipated to grow at a CAGR of 5.5% through 2035, driven by continuous advancements in surgical techniques and the increasing focus on patient satisfaction and outcomes.

Europe follows closely behind as a significant market for femoral components, holding a share of approximately 30% in 2023. The region is characterized by a strong emphasis on healthcare innovation, high rates of hip arthroplasty procedures, and a growing elderly demographic. Countries such as Germany and the United Kingdom exhibit substantial demand for advanced femoral component technologies. Moreover, the increasing focus on minimally invasive surgeries is expected to bolster the growth of the femoral components market in Europe. The Asia Pacific region shows promise for substantial growth due to rising healthcare expenditures, improving infrastructure, and increasing awareness of orthopedic solutions among the population.

Opportunities

The femoral components market is poised for significant growth opportunities, particularly in emerging economies where healthcare infrastructure is improving. The rising awareness of joint health, coupled with increased disposable incomes, is leading to a growing demand for orthopedic surgeries in regions such as Asia Pacific and Latin America. As healthcare systems in these areas continue to develop, the adoption of advanced orthopedic technologies will become more prevalent, offering manufacturers a fertile ground for expansion. Additionally, the shift toward preventive healthcare and early intervention strategies will likely enhance patient engagement, encouraging timely surgical treatments for joint issues, thus driving demand for femoral components.

Furthermore, ongoing research and development in materials and technologies present significant opportunities for market players to innovate and differentiate their product offerings. Advances in biocompatible materials, 3D printing for personalized implants, and minimally invasive surgical techniques are expected to revolutionize the orthopedic landscape. Companies that can leverage these innovations to enhance patient outcomes while reducing recovery times will likely gain a competitive edge in the femoral components market. Collaborative efforts between manufacturers, healthcare providers, and research institutions will also be vital in addressing evolving patient needs and driving the future growth of the market.

Threats

The femoral components market faces several threats that could impact growth and profitability. One of the most significant challenges is the increasing regulatory scrutiny surrounding orthopedic implants, particularly concerning safety and efficacy. Regulatory bodies are becoming more stringent in their approval processes, which could lead to delays in the introduction of new products and innovations. Additionally, negative publicity related to certain implant materials, such as metal-on-metal components, may deter patients and healthcare providers from considering specific options, reducing overall market growth. Complications arising from surgical procedures, such as infections or implant failures, also pose a threat, as they can lead to increased revision rates and patient dissatisfaction.

Another potential threat is the competitive landscape, characterized by the presence of numerous established players and the entry of new companies. Price competition may intensify as manufacturers strive to capture market share, leading to reduced profit margins for various players in the market. Furthermore, the ongoing trend of outpatient surgeries and the increasing preference for alternative treatment options, such as non-surgical interventions, could limit the growth potential of the femoral components market. As healthcare providers continually seek to improve patient outcomes and reduce costs, the pressure on femoral component manufacturers to innovate and provide high-quality products at competitive prices will only increase.

Competitor Outlook

• DePuy Synthes (Johnson & Johnson)
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew
• Medtronic plc
• Exactech, Inc.
• MicroPort Scientific Corporation
• Arthrex, Inc.
• Wright Medical Group N.V.
• Conmed Corporation
• NuVasive, Inc.
• Orthofix Medical Inc.
• Acumed LLC
• Corin Group PLC
• Hanger, Inc.

The competitive landscape of the femoral components market is characterized by the presence of several well-established companies that dominate market share through their robust product portfolios, strong distribution networks, and extensive research and development capabilities. Leading players such as DePuy Synthes and Stryker Corporation have made significant investments in innovation, focusing on developing advanced femoral component technologies that cater to the evolving needs of patients and surgeons. These companies consistently emphasize quality, performance, and improved patient outcomes in their product offerings, which is crucial for maintaining their market position amid growing competition.

Furthermore, companies like Zimmer Biomet and Smith & Nephew are also significant contributors to the femoral components market, leveraging their global reach and established relationships with healthcare providers. Their commitment to research and development enables them to introduce innovative solutions and expand their product lines, addressing the diverse needs of the orthopedic community. Additionally, these leading manufacturers are actively involved in partnerships and collaborations with healthcare institutions to enhance their understanding of patient requirements and improve the design and functionality of femoral components.

Emerging players, such as Exactech and MicroPort Scientific, are also making their mark in the femoral components market by focusing on niche segments and offering specialized products. These companies are particularly agile, often able to respond quickly to market demands and changes, thereby capturing opportunities that larger players may overlook. As the market evolves, the competition is expected to intensify, requiring all players to continuously innovate and adapt in order to maintain their relevance and profitability.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Acumed LLC
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hanger, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Arthrex, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Exactech, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 NuVasive, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smith & Nephew
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Corin Group PLC
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Conmed Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Orthofix Medical Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Wright Medical Group N.V.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Zimmer Biomet Holdings, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 MicroPort Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 DePuy Synthes (Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Femoral Components Market, By Application
    • 6.1.1 Total Hip Arthroplasty
    • 6.1.2 Hip Resurfacing
    • 6.1.3 Revision Hip Arthroplasty
    • 6.1.4 Hip Fracture Management
    • 6.1.5 Others
  • 6.2 Femoral Components Market, By Product Type
    • 6.2.1 Cemented Femoral Components
    • 6.2.2 Cementless Femoral Components
    • 6.2.3 Hybrid Femoral Components
    • 6.2.4 Reverse Hybrid Femoral Components
    • 6.2.5 Modular Femoral Components
  • 6.3 Femoral Components Market, By Material Type
    • 6.3.1 Metal-on-Polyethylene
    • 6.3.2 Ceramic-on-Polyethylene
    • 6.3.3 Ceramic-on-Ceramic
    • 6.3.4 Metal-on-Metal
    • 6.3.5 Others
  • 6.4 Femoral Components Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Orthopedic Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Platforms
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Femoral Components Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Femoral Components market is categorized based on

By Product Type

• Cemented Femoral Components
• Cementless Femoral Components
• Hybrid Femoral Components
• Reverse Hybrid Femoral Components
• Modular Femoral Components

By Application

• Total Hip Arthroplasty
• Hip Resurfacing
• Revision Hip Arthroplasty
• Hip Fracture Management
• Others

By Distribution Channel

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Online Platforms
• Others

By Material Type

• Metal-on-Polyethylene
• Ceramic-on-Polyethylene
• Ceramic-on-Ceramic
• Metal-on-Metal
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• DePuy Synthes (Johnson & Johnson)
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew
• Medtronic plc
• Exactech, Inc.
• MicroPort Scientific Corporation
• Arthrex, Inc.
• Wright Medical Group N.V.
• Conmed Corporation
• NuVasive, Inc.
• Orthofix Medical Inc.
• Acumed LLC
• Corin Group PLC
• Hanger, Inc.